Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing Heart: A Multisystems Approach

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation: Heart Failure

• Publication date

  2014-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.114.001469PMID 25236884PMCID PMC4241130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts

  2014cited by this paper
• A Role for Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1 in the Control of Mitochondrial Dynamics During Postnatal Cardiac Growth

  2014cited by this paper
• Succinate: a metabolic signal in inflammation.

  2014cited by this paper
• A Role for Peroxisome Proliferator-activated Receptor γ Coactivator 1 (PGC-1) in the Regulation of Cardiac Mitochondrial Phospholipid Biosynthesis*♦

  2013cited by this paper
• SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways.

  2013cited by this paper
• SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks.

  2013cited by this paper
• Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.

  2013cited by this paper
• The evolving role of mitochondria in metabolism Transcriptional integration of mitochondrial biogenesis

  2012cited by this paper
• Voluntary running in mice beneficially modulates myocardial ischemic tolerance, signaling kinases, and gene expression patterns.

  2012cited by this paper
• Inherited Cardiomyopathies

  2012cited by this paper
• Mitochondrial Protein Acylation and Intermediary Metabolism: Regulation by Sirtuins and Implications for Metabolic Disease*

  2012cited by this paper
• Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart

  2011cited by this paper
• Reciprocal Transcriptional Regulation of Metabolic and Signaling Pathways Correlates With Disease Severity in Heart Failure

  2011cited by this paper
• Inherited cardiomyopathies.

  2011cited by this paper
• On acetyl-CoA as a gauge of cellular metabolic state.

  2011cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.

  2010cited by this paper
• PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.

  2009cited by this paper
• Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

  2009cited by this paper
• Acetylation of mitochondrial proteins.

  2009cited by this paper
• Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart.

  2008cited by this paper
• The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload.

  2007cited by this paper
• Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure.

  2006cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism.

  2006cited by this paper
• On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine

  2006cited by this paper
• Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion.

  2006cited by this paper
• PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Expression profiling reveals differences in metabolic gene expression between exercise‐induced cardiac effects and maladaptive cardiac hypertrophy

  2005cited by this paper
• Metabolic control through the PGC-1 family of transcription coactivators.

  2005cited by this paper
• Mitochondrial energy metabolism in heart failure: a question of balance.

  2005cited by this paper
• ATP flux through creatine kinase in the normal, stressed, and failing human heart.

  2005cited by this paper
• Gene expression profiling of exercise-induced cardiac hypertrophy in rats.

  2005cited by this paper
• Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vitro

  2004cited by this paper
• Estrogen-Related Receptor α Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle

  2004cited by this paper
• Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

  2004cited by this paper
• Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a "vasoconstrictor" with a unique hemodynamic profile.

  2004cited by this paper
• ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease.

  2004cited by this paper
• Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.

  2004cited by this paper
• Linking Gene Expression to Function: Metabolic Flexibility in the Normal and Diseased Heart

  2004cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles

  2003cited by this paper
• Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles.

  2003cited by this paper
• Very-Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice

  2003cited by this paper
• On Differential Variability of Expression Ratios: Improving Statistical Inference about Gene Expression Changes from Microarray Data

  2001cited by this paper
• Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse.

  2001cited by this paper
• Mitochondrial defects in cardiomyopathy and neuromuscular disease.

  2000cited by this paper
• Inborn Errors of Mitochondrial Fatty Acid Oxidation

  2000cited by this paper
• A nuclear complex containing PPARalpha/RXRalpha is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function.

  2000cited by this paper
• Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

  2000cited by this paper
• A nuclear complex containing PPARα/RXRα is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function

  2000cited by this paper
• Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo

  1998cited by this paper
• A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

  1997cited by this paper
• Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

  1997cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle.

  1996cited by this paper
• Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters.

  1996cited by this paper
• Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.

  1994cited by this paper
• Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat.

  1994cited by this paper
• Inherited cardiomyopathies.

  1994cited by this paper
• Tissue specific and developmental expression of rat long-and medium-chain acyl-CoA dehydrogenases.

  1993cited by this paper
• Long-term performance of Star-Edwards silastic ball valves and St Jude Medical bi-leaflet valves

  1990cited by this paper
• Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium.

  1990cited by this paper
• Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism

  1990cited by this paper
• Nucleotide sequence of medium-chain acyl-CoA dehydrogenase mRNA and its expression in enzyme-deficient human tissue.

  1987cited by this paper
• The inborn errors of mitochondrial fatty acid oxidation

  1987cited by this paper
• Increased glycolytic metabolism in cardiac hypertrophy and congestive failure.

  1970cited by this paper
• The metabolism of the heart.

  1955cited by this paper
• The metabolism of the heart.

  1954cited by this paper
• A Role for Peroxisome Proliferator-Activated Receptor γ Coactivator-1 in the Control of Mitochondrial Dynamics During Postnatal Cardiac Growth

  year unknowncited by this paper

• Plasma and pericardial fluid metabolomic signatures of patients with ischemic heart disease.

  2026cites this paper
• Targeting the undruggable transcription factor, KLF5, with a peptidomimetic small molecule, NC114, attenuates pressure overload-induced cardiac remodeling and fibrosis

  2026cites this paper
• Systemic Metabolomic Remodeling in Pressure Overload-Induced Heart Failure Indicates Modulation of a Gut–Liver–Heart Axis by the Adiponectin Receptor Agonist ALY688

  2026cites this paper
• Ketone therapy improves cardiac function and structure in rodents with heart failure: A systematic review and meta-analysis.

  2025cites this paper
• Mitochondrial Dysfunction in the Cardiovascular Disease Continuum: Problems of Studying the Progression During the Follow-Up of the Pathologies

  2025cites this paper
• Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment

  2025cites this paper
• Mitochondrial function: A new direction for the targeted treatment of cardiovascular diseases with Chinese herbal medicine

  2025cites this paper
• Athlete's Heart Revisited: Historical, Clinical, and Molecular Perspectives.

  2025cites this paper
• Omics-based Approach Towards Macrophages: New Perspectives of Biology and Function in the Normal and Diseased Heart

  2025cites this paper
• Cardiac Ischaemia–Reperfusion Injury: Pathophysiology, Therapeutic Targets and Future Interventions

  2025cites this paper
• Retinoic Acid Signaling & Metabolism in Heart Failure.

  2025cites this paper
• Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development

  2025cites this paper
• Reprogramming heart failure: physiological orchestration and mechanistic decoding of exercise benefits

  2025cites this paper
• Targeting Ketone Body Metabolism Improves Cardiac Function and Hemodynamics in Patients With Heart Failure: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Mechanisms of metabolic transition in hypertrophic cardiomyopathy

  2025cites this paper
• Valine acts as an early biomarker and exacerbates pathological cardiac hypertrophy by impairing mitochondrial quality control.

  2025cites this paper
• Integrated multi-omics mapping of mitochondrial dysfunction and substrate preference in Barth syndrome cardiac tissue

  2025influential citation
• Role of branched chain amino acid metabolism on aging

  2025cites this paper
• Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction

  2025cites this paper
• Glycometabolic cardiac dysfunction in HFpEF: lessons from multi-omics studies.

  2025cites this paper
• Mitochondrial quality control: Biochemical mechanism of cardiovascular disease.

  2025cites this paper
• α‑ketoglutarate protects against septic cardiomyopathy by improving mitochondrial mitophagy and fission

  2025cites this paper
• Metabolic dysregulation in the heart in obesity-associated HFpEF

  2025cites this paper
• Evidence of Hyperacetylation of Mitochondrial Regulatory Proteins in Left Ventricular Myocardium of Dogs with Chronic Heart Failure

  2025cites this paper
• The regulatory role of exercise in heart failure and myocardial energy metabolism: A review

  2025cites this paper
• Towards Metabolomic-Based Precision Approaches for Classifying and Treating Heart Failure

  2024cites this paper
• A transcriptional regulatory mechanism of genes in the tricarboxylic acid cycle in the heart

  2024cites this paper
• Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole

  2024cites this paper
• Mitochondrial MOF regulates energy metabolism in heart failure via ATP5B hyperacetylation.

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Gene expression profiles, potential targets and treatments of cardiac remodeling

  2024cites this paper
• Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis

  2024cites this paper
• Characteristics of Myocardial Structure and Central Carbon Metabolism during the Early and Compensatory Stages of Cardiac Hypertrophy.

  2024cites this paper
• UCP1‐dependent brown adipose activation accelerates cardiac metabolic remodeling and reduces initial hypertrophic and fibrotic responses to pathological stress

  2024cites this paper
• Toxicometabolomics-based cardiotoxicity evaluation of Thiazolidinedione exposure in human-derived cardiomyocytes

  2024cites this paper
• The role of acetylation in obesity-induced cardiac metabolic alterations

  2024cites this paper
• Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome

  2024cites this paper
• Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fraction

  2024cites this paper
• Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities

  2024cites this paper
• Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction.

  2024cites this paper
• Hippo pathway activated by circulating reactive oxygen species mediates cardiac diastolic dysfunction after acute kidney injury.

  2024cites this paper
• Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection Fraction

  2024cites this paper
• The correlation between Fischer’s ratio and the risk of cardiac dysfunction in heart failure patients

  2024cites this paper
• Metabolomic insights in advanced cardiomyopathy of chronic chagasic and idiopathic patients that underwent heart transplant

  2024cites this paper
• Metabolite signaling in the heart

  2023cites this paper
• Comprehensive Analysis of Mitochondrial Dynamics Alterations in Heart Diseases

  2023cites this paper
• Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

  2023cites this paper
• Functional Impact of Alternative Metabolic Substrates in Failing Human Cardiomyocytes

  2023cites this paper
• Metabolic Dysfunction in Aortic Stenosis: A Key Piece of the Pathophysiological Puzzle.

  2023cites this paper
• Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levels

  2023cites this paper
• Myocardial Metabolism in Heart Failure

  2023cites this paper
• Changes of energy metabolism in failing heart and its regulation by SIRT3

  2023cites this paper
• Myocardial Metabolic Reprogramming in HFpEF

  2023cites this paper
• Role of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic Phenotype

  2023cites this paper
• From Beats to Metabolism: The Heart at the Core of Interorgan Crosstalk.

  2023cites this paper
• Targeting mitochondrial impairment for the treatment of cardiovascular diseases: from hypertension to ischemia reperfusion injury, searching for new pharmacological targets.

  2023cites this paper
• Raising NAD+ Level Stimulates Short-Chain Dehydrogenase/Reductase Proteins to Alleviate Heart Failure Independent of Mitochondrial Protein Deacetylation

  2023cites this paper
• α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction

  2023cites this paper
• Shengxian decoction protects against chronic heart failure in a rat model via energy regulation mechanisms

  2023cites this paper
• Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy

  2023cites this paper
• Post-Translational Modification of Drp1 is a Promising Target for Treating Cardiovascular Diseases

  2023cites this paper
• Progressive Cardiac Metabolic Defects Accompany Diastolic and Severe Systolic Dysfunction in Spontaneously Hypertensive Rat Hearts

  2023cites this paper
• Targeting Mitochondrial Metabolism to Save the Failing Heart

  2023cites this paper
• USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes

  2023cites this paper
• Quantitative Profiling of Serum Carnitines Facilitates the Etiology Diagnosis and Prognosis Prediction in Heart Failure

  2023cites this paper
• Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

  2023cites this paper
• Ketones and the Heart: Metabolic Principles and Therapeutic Implications

  2023cites this paper
• Ginsenoside Rb1 promotes the activation of PPARα pathway via inhibiting FADD to ameliorate heart failure.

  2023cites this paper
• Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

  2023cites this paper
• Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction

  2023cites this paper
• RIP140 deficiency enhances cardiac fuel metabolism and protects mice from heart failure

  2023cites this paper
• Molecular mechanisms underlying sarcopenia in heart failure

  2023cites this paper
• Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance in cardiac and skeletal muscles.

  2023cites this paper
• Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease

  2023cites this paper
• Landscape of molecular crosstalk between SARS-CoV-2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune-inflammation

  2023cites this paper
• Ectopic expression of SARS-CoV-2 S and ORF-9B proteins alters metabolic profiles and impairs contractile function in cardiomyocytes

  2023cites this paper
• Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure

  2022cites this paper
• Sex Differences in Cardiac Pathology of SARS-CoV2 Infected and Trypanosoma cruzi Co-infected Mice

  2022cites this paper
• Metabolism disorder promotes isoproterenol-induced myocardial injury in mice with high temperature and high humidity and high-fat diet

  2022cites this paper
• Lymphangiogenesis contributes to exercise-induced physiological cardiac growth

  2022cites this paper
• Branched-Chain Amino Acid Metabolism in the Failing Heart

  2022cites this paper
• A mouse model of inherited choline kinase β-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia

  2022cites this paper
• Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy

  2022cites this paper
• Metabolic Reprogramming, Gut Dysbiosis, and Nutrition Intervention in Canine Heart Disease

  2022cites this paper
• Metabolomic and Transcriptomic Signatures of Chemogenetic Heart Failure.

  2022cites this paper
• Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development

  2022cites this paper
• Linoleate-Enrichment of Mitochondrial Cardiolipin Molecular Species Is Developmentally Regulated and a Determinant of Metabolic Phenotype

  2022cites this paper
• Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy

  2022cites this paper
• BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice

  2022cites this paper
• Mitochondrial dysfunction in heart failure and its therapeutic implications

  2022cites this paper
• Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)

  2022cites this paper
• Branched-chain amino acids in cardiovascular disease

  2022cites this paper
• Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells

  2022cites this paper
• Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure

  2022cites this paper
• Long-term epigenetic and metabolomic changes in the mouse ventricular myocardium after exertional heat stroke.

  2022cites this paper
• Biology of myocardial recovery in advanced heart failure with long-term mechanical support.

  2022cites this paper
• Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation

  2022cites this paper
• Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma

  2022cites this paper
• Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies

  2022cites this paper
• PERM1 regulates energy metabolism in the heart via ERRα/PGC−1α axis

  2022cites this paper